340.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health (ELV) Target Price Lowered by UBS Analyst | ELV Stock News - GuruFocus
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the Firm - GlobeNewswire
Elevance Health stock hits 52-week low at 339.38 USD - Investing.com
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV - TradingView
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - GlobeNewswire
Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT - MSN
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bernstein Maintains a Buy on Elevance Health (ELV), Sets a $585 PT - Insider Monkey
Guggenheim Adjusts Price Target on Elevance Health to $447 From $518, Maintains Buy Rating - MarketScreener
Earnings Preview: Elevance Health (ELV) Q2 Earnings Expected to Decline - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - FinancialContent
ELV COURT NOTICE: Elevance Health, Inc. Investors may have - GlobeNewswire
Elevance Health (ELV): Barclays Lowers Price Target Amid Maintai - GuruFocus
Deadline Soon: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, and Elevance, and Encourages Investors to Contact the Firm - Morningstar
Elevance Health, Inc. Investors: Please contact the Portnoy - GlobeNewswire
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged - MSN
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - Morningstar
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy - Yahoo Finance
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - simplywall.st
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - FinancialContent
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
Is Weakness In Elevance Health, Inc. (NYSE:ELV) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for - GlobeNewswire
INVESTOR ALERT: Berger Montague Advises Elevance Health (ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView
ELV Lead Plaintiff Deadline ApproachingRobbins LLP Reminds Investors to Get Information About Leading the Class Action Against Elevance Health, Inc. - The Malaysian Reserve
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating - MSN
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are - GlobeNewswire
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 11 Deadline (NYSE:ELV) - TradingView
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
June 13Parkview Health and Anthem still at odds ahead of contract deadline - Fort Wayne Business Weekly
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
ELV CLASS ACTION: Invest in Elevance Health, Inc.? Contact - GlobeNewswire
ELEVANCE HEALTH (ELV) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By July 11, 2025 - TradingView
$1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much TodayElevance Health (NYSE:ELV) - Benzinga
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Reasonably Well - Yahoo Finance
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit - GuruFocus
UnitedHealth's Medical Membership Rises: Can It Maintain the Momentum? - The Globe and Mail
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):